JP2022532877A5 - - Google Patents

Info

Publication number
JP2022532877A5
JP2022532877A5 JP2021566284A JP2021566284A JP2022532877A5 JP 2022532877 A5 JP2022532877 A5 JP 2022532877A5 JP 2021566284 A JP2021566284 A JP 2021566284A JP 2021566284 A JP2021566284 A JP 2021566284A JP 2022532877 A5 JP2022532877 A5 JP 2022532877A5
Authority
JP
Japan
Application number
JP2021566284A
Other languages
Japanese (ja)
Other versions
JPWO2020227563A5 (https=
JP2022532877A (ja
JP7617030B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/031925 external-priority patent/WO2020227563A1/en
Publication of JP2022532877A publication Critical patent/JP2022532877A/ja
Publication of JPWO2020227563A5 publication Critical patent/JPWO2020227563A5/ja
Publication of JP2022532877A5 publication Critical patent/JP2022532877A5/ja
Application granted granted Critical
Publication of JP7617030B2 publication Critical patent/JP7617030B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021566284A 2019-05-08 2020-05-07 Jak阻害剤 Active JP7617030B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962845119P 2019-05-08 2019-05-08
US62/845,119 2019-05-08
US201962884588P 2019-08-08 2019-08-08
US62/884,588 2019-08-08
PCT/US2020/031925 WO2020227563A1 (en) 2019-05-08 2020-05-07 Jak inhibitors

Publications (4)

Publication Number Publication Date
JP2022532877A JP2022532877A (ja) 2022-07-20
JPWO2020227563A5 JPWO2020227563A5 (https=) 2023-05-16
JP2022532877A5 true JP2022532877A5 (https=) 2023-05-16
JP7617030B2 JP7617030B2 (ja) 2025-01-17

Family

ID=73051620

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021566284A Active JP7617030B2 (ja) 2019-05-08 2020-05-07 Jak阻害剤

Country Status (13)

Country Link
US (1) US11136329B2 (https=)
EP (1) EP3966209A4 (https=)
JP (1) JP7617030B2 (https=)
KR (1) KR102916168B1 (https=)
CN (1) CN114269734B (https=)
AU (1) AU2020267661A1 (https=)
BR (1) BR112021022380A2 (https=)
CA (1) CA3139277A1 (https=)
IL (1) IL287876A (https=)
MX (1) MX2021013602A (https=)
SG (1) SG11202112362YA (https=)
TW (1) TWI865525B (https=)
WO (1) WO2020227563A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7617030B2 (ja) 2019-05-08 2025-01-17 ビマラン バイオサイエンシーズ,インク. Jak阻害剤
KR20220051351A (ko) 2019-08-08 2022-04-26 비말란 바이오사이언스즈, 인크. Jak 억제제
CN114644633B (zh) * 2020-12-18 2026-02-03 北京诺诚健华医药科技有限公司 杂环类jak抑制剂
KR102637915B1 (ko) * 2021-06-25 2024-02-19 한국화학연구원 유비퀴틴 프로테오좀 경로를 통해 비티케이 분해작용을 가지는 신규한 이작용성 헤테로사이클릭 화합물과 이의 용도
WO2023107705A1 (en) 2021-12-10 2023-06-15 Incyte Corporation Bicyclic amines as cdk12 inhibitors

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA200802685B (en) 2005-09-30 2009-10-28 Vertex Pharma Deazapurines useful as inhibitors of janus kinases
TWI398252B (zh) 2006-05-26 2013-06-11 諾華公司 吡咯并嘧啶化合物及其用途
EP2108019A2 (en) 2007-01-30 2009-10-14 Biogen Idec MA, Inc. 1-h-pyrazolo[3,4b]pyrimidine derivatives and their use as modulators of mitotic kinases
UY31631A1 (es) 2008-02-06 2009-09-30 Nuevos derivados de 7-fenil-7h-pirrolo-[2,3d]-pirimidin-2-il-amino, sales de los mismos, procesos para su preparacion, composiciones farmacéuticas que los comprenden y aplicaciones
US9242987B2 (en) 2009-10-20 2016-01-26 Cellzome Limited Heterocyclyl pyrazolopyrimidine analogues as JAK inhibitors
BR112012027803A2 (pt) 2010-04-30 2016-08-09 Cellzome Ltd compostos de pirazol como inibidores de jak
US8637529B2 (en) 2010-06-11 2014-01-28 AbbYie Inc. Pyrazolo[3,4-d]pyrimidine compounds
WO2012143320A1 (en) * 2011-04-18 2012-10-26 Cellzome Limited (7h-pyrrolo[2,3-d]pyrimidin-2-yl)amine compounds as jak3 inhibitors
WO2013041605A1 (en) * 2011-09-20 2013-03-28 Cellzome Limited Pyrazolo[4,3-c]pyridine derivatives as kinase inhibitors
WO2014001973A1 (en) 2012-06-29 2014-01-03 Pfizer Inc. NOVEL 4-(SUBSTITUTED-AMINO)-7H-PYRROLO[2,3-d]PYRIMIDINES AS LRRK2 INHIBITORS
RU2719477C2 (ru) 2015-06-22 2020-04-17 Оно Фармасьютикал Ко., Лтд. Соединение, ингибирующее brk
CN108864057B (zh) * 2017-05-16 2020-03-31 山东大学 含有4-氨基吡唑结构的jak与hdac双靶点抑制剂及其制备方法和应用
JP7617030B2 (ja) 2019-05-08 2025-01-17 ビマラン バイオサイエンシーズ,インク. Jak阻害剤
KR20220051351A (ko) 2019-08-08 2022-04-26 비말란 바이오사이언스즈, 인크. Jak 억제제
BR112022005608A2 (pt) 2019-09-25 2022-09-06 Vimalan Biosciences Inc Inibidores de jak

Similar Documents

Publication Publication Date Title
JP2022532877A5 (https=)
JP2024522210A5 (https=)
JP1693475S (https=)
CN305534562S (https=)
CN305533322S (https=)
CN305535813S (https=)
CN305535759S (https=)
CN305535580S (https=)
CN305535257S (https=)
CN305534620S (https=)
CN305533481S (https=)
CN305532058S (https=)
CN305531344S (https=)
CN305529862S (https=)
CN305529476S (https=)
CN305529201S (https=)
CN305529126S (https=)
CN305528452S (https=)
CN305528024S (https=)
CN305526935S (https=)
CN305966867S (https=)
CN305960143S (https=)
CN305883333S (https=)
CN305876283S (https=)
CN305870077S (https=)